MERLIN-TIMI 36 patients. The results were presented at the 2007 European Society of Cardiology meeting in Vienna and subsequently published. [6] Compared to the placebo cohort, patients treated ...

1 point = 4.7% 2 points = 8.3% 3 points = 13.2% 4 points = 19.9% 5 points = 26.2% 6 or 7 points = 40.9% Note that the TIMI score is different that TIMI grade coronary flow TIMI 0 flow indicates no ...

Patients with cardiogenic shock, and those with cardiac arrest who survived beyond the SPECT study, were not specifically excluded. Whether, and to what extent, these strongly prognostic TIMI risk ...

Abstract presented at: The American College of Cardiology Scientific Sessions; March 29-31, 2025; Chicago, IL. Abstract ...

Among patients with AF receiving anticoagulation therapy, epistaxis is common, frequently recurrent, and associated with anticoagulant discontinuation.

Christian T. Ruff, MD, MPH, of Brigham and Women's Hospital, discusses new data comparing abelacimab with rivaroxaban in patients with atrial fibrillation presented at the American College of ...

Cambridge, USA-based Anthos Therapeutics presented two new analyses from its landmark AZALEA-TIMI 71 study at the American ...

In an interview with Managed Healthcare Executive, Christian T. Ruff, M.D., M.P.H., director of general cardiology at Brigham and Women's Hospital and associate professor at Harvard Medical School, ...